Letter to the Editors
Oral direct-acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus–related cirrhosis
Address reprint requests to Paul Y. Kwo, M.D., Department of Medicine, Indiana University School of Medicine, 975 West Walnut, IB 327, Indianapolis, IN 46202-5121. Telephone: 317-274-3090; FAX: 317-274-3106; E-mail: firstname.lastname@example.org
No abstract is available for this article.